Palliative treatment of hepatocellular carcinoma. Is it justified?

被引：0
|
作者：
Michalowicz, B [1 ]
Alsharabi, A [1 ]
Pawlak, J [1 ]
Krawczyk, M [1 ]
Paczkowski, PM [1 ]
Malkowski, P [1 ]
Zieniewicz, K [1 ]
Nyckowski, P [1 ]
Karwowski, A [1 ]
Rowinski, O [1 ]
Jaworski, M [1 ]
Leowska, E [1 ]
机构：
[1] Univ Warsaw, Dept Gen & Liver Surg, Warsaw, Poland
来源：
8TH WORLD CONGRESS OF THE INTERNATIONAL GASTRO-SURGICAL CLUB | 1998年
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
In the period 1992-1995 313 patients were treated for malignant liver tumors. The diagnosis of hepatocellular carcinoma was established in 118 cases. In 84 cases the tumor was inoperable. We present our experience with intraoperative alcoholization (19 cases) and perarterial chemoembolization (43 cases). None of these methods is effective in all cases. Etanol injection resulted in temporary reduction of the neoplasmatic mass in 73%. Repeated chemoembolization resulted in significant improvement in 20 cases, in 16 cases it's effect was doubtful and in 7 cases it was evidently uneffective. 18 patients (42%) survived more than one year, in 15 of them no progress of malignancy was noticed.
引用
收藏
页码：413 / 418
页数：6
相关论文
共 50 条
  • [31] The application of RNAi in hepatocellular carcinoma.
    黄锦
    林菊生
    中华肝脏病杂志, 2004, (09) : 49 - 49
  • [32] Colchicine delays hepatocellular carcinoma.
    Domville, D
    Arrieta, O
    Rodríguez, JL
    Rosas, V
    de León, SP
    Kershenobich, D
    Gómez-Roel, X
    León-Rodríguez, E
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 350S - 350S
  • [33] Hepatitis viruses and hepatocellular carcinoma.
    Rosmorduc, O
    Paterlini, P
    Poupon, R
    Brechot, C
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1999, 23 (03): : 363 - 375
  • [34] Telomerase,activity in hepatocellular carcinoma.
    Park, SH
    Kwon, SW
    Kim, KS
    Chae, KJ
    Oh, BK
    Park, YN
    Choi, JS
    Lee, WJ
    Park, C
    Kim, BR
    HEPATOLOGY, 2002, 36 (04) : 447A - 447A
  • [35] Serum erythropoietin in hepatocellular carcinoma.
    Malaguarnera, M
    Bentivegna, P
    DiFazio, I
    Laurino, A
    Romano, M
    Trovato, BA
    BULLETIN DU CANCER, 1996, 83 (12) : 977 - 980
  • [36] Heterogeneity of pediatric hepatocellular carcinoma.
    D'Souza, Amber M.
    Towbin, Alexander
    Bondoc, Alexander
    Gupta, Anita
    Nathan, Jaimie
    Alonso, Maria
    Tiao, Greg
    Geller, James I.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [37] Expression of neurothelin in hepatocellular carcinoma.
    Rizzo, A
    Aragona, E
    Dino, O
    Pisa, R
    Raiata, F
    Realmuto, A
    Albanese, M
    Guerrera, D
    Parisi, P
    Simonetti, R
    Pagliaro, L
    Malizia, G
    TISSUE ANTIGENS, 1996, 48 (4-II): : EC312 - EC312
  • [38] Gastric carcinoma: when is palliative gastrectomy justified?
    Scheidbach, Hubert
    Lippert, Hans
    Meyer, Frank
    ONCOLOGY REVIEWS, 2010, 4 (02) : 127 - 132
  • [39] Clinical outcomes of hepatocellular carcinoma variants compared to hepatocellular carcinoma.
    Zakka, Katerina Mary
    Jiang, Renjian
    Alese, Olatunji B.
    Shaib, Walid Labib
    Wu, Christina
    Wedd, Joel
    Sellers, Marty T.
    Behera, Madhusmita
    El-Rayes, Bassel F.
    Akce, Mehmet
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [40] Gene therapy of hepatocellular carcinoma.
    王学浩
    李国强
    中华肝脏病杂志, 2004, (11) : 56 - 57
12345